speb/financial-data huggingface dataset:
AMGN cash_flow (quarterly, 2026-03-31) — Change In Receivables: 413000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 142000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -721000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 413000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Changes In Cash: 2909000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Common Stock: 34030000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -1358000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 9190000000.00
AMGN income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2744000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 16583000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Current Assets: 31475000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Current Debt: 5437000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 5437000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 24955000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -176000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Deferred Tax: -176000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Depreciation: 1116000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1116000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1116000000.00
AMGN income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 544000000.00
AMGN income_statement (quarterly, 2026-03-31) — Diluted EPS: 3.34
AMGN income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1819000000.00
AMGN income_statement (quarterly, 2026-03-31) — EBIT: 2741000000.00
AMGN income_statement (quarterly, 2026-03-31) — EBITDA: 3857000000.00
AMGN cash_flow (quarterly, 2026-03-31) — End Cash Position: 12038000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 1436000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Finished Goods: 1712000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Foreign Currency Translation Adjustments: -207000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 1477000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 143000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -190000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Goodwill: 18674000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 40053000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Gross PPE: 17516000000.00
AMGN income_statement (quarterly, 2026-03-31) — Gross Profit: 5874000000.00
AMGN income_statement (quarterly, 2026-03-31) — Interest Expense: 657000000.00
AMGN income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 657000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Inventory: 6186000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Invested Capital: 66513000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -716000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 3964000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 51886000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 51886000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 3964000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -833000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Net Debt: 45285000000.00
AMGN income_statement (quarterly, 2026-03-31) — Net Income: 1819000000.00
AMGN income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1819000000.00
AMGN income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1819000000.00
AMGN income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1819000000.00
AMGN income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1819000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1819000000.00
AMGN income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1819000000.00
AMGN income_statement (quarterly, 2026-03-31) — Net Interest Income: -657000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 3131000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 3131000000.00
AMGN income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -657000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -337000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -4000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Net PPE: 8216000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -712000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -30863000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 1344000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 1344000000.00
AMGN income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 3857000000.00
AMGN income_statement (quarterly, 2026-03-31) — Normalized Income: 1819000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 2189000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 143000000.00
AMGN income_statement (quarterly, 2026-03-31) — Operating Income: 2666000000.00
AMGN income_statement (quarterly, 2026-03-31) — Operating Revenue: 8218000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 539700000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 4113000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 17000000.00
AMGN income_statement (quarterly, 2026-03-31) — Other Income Expense: 75000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 21379000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -67000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 12760000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 2365000000.00
AMGN income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 75000000.00
AMGN income_statement (quarterly, 2026-03-31) — Other Operating Expenses: -113000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Payables: 2935000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 19518000000.00
AMGN income_statement (quarterly, 2026-03-31) — Pretax Income: 2084000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -712000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Raw Materials: 1048000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Receivables: 9138000000.00
AMGN income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2744000000.00
AMGN income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1116000000.00
AMGN cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -833000000.00
AMGN income_statement (quarterly, 2026-03-31) — Research And Development: 1719000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -24650000000.00
AMGN income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1602000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Share Issued: 539700000.00
AMGN cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 75000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 9190000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -30863000000.00
AMGN income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
AMGN income_statement (quarterly, 2026-03-31) — Tax Provision: 265000000.00
AMGN income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.13
AMGN balance_sheet (quarterly, 2026-03-31) — Total Assets: 92504000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 61076000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Total Debt: 57323000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 9190000000.00
AMGN income_statement (quarterly, 2026-03-31) — Total Expenses: 5952000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 83314000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 61029000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 58359000000.00
AMGN income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 2666000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 2764000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Work In Process: 3426000000.00
AMGN balance_sheet (quarterly, 2026-03-31) — Working Capital: 6520000000.00
AMGN.TO balance_sheet (annual, 2021-12-31) — Current Provisions: 542000000.00
AMGN.TO balance_sheet (annual, 2021-12-31) — Duefrom Related Parties Current: 780000000.00
AMGN.TO cash_flow (annual, 2021-12-31) — Earnings Losses From Equity Investments: 33000000.00
AMGN.TO cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 0.00
AMGN.TO balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 48000000.00
AMGN.TO income_statement (annual, 2021-12-31) — Other Special Charges: 1505000000.00
AMGN.TO cash_flow (annual, 2021-12-31) — Purchase Of Investment: -8900000000.00
AMGN.TO cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
AMGN.TO income_statement (annual, 2021-12-31) — Special Income Charges: -1505000000.00
AMGN.TO balance_sheet (annual, 2021-12-31) — Taxes Receivable: 164000000.00
AMGN.TO income_statement (annual, 2021-12-31) — Total Unusual Items: -1505000000.00
AMGN.TO income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: -1505000000.00
AMGN.TO balance_sheet (annual, 2021-12-31) — Unrealized Gain Loss: 0.00
AMGN.TO income_statement (annual, 2022-12-31) — +Operating Expense: 10351000000.00
AMGN.TO income_statement (annual, 2022-12-31) — +Total Revenue: 26323000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 1572000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 5563000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -9283000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 9774618731.00
AMGN.TO income_statement (annual, 2022-12-31) — Basic EPS: 0.67
AMGN.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 7989000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 4201000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -936000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 32514000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 7629000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 9305000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -4196000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -4037000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -6044000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 9721000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Change In Account Payable: 154000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 943000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: -418000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Change In Inventory: -742000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 258000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -182000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Change In Payable: -264000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 679000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Change In Receivables: -746000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Change In Tax Payable: -418000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: -733000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -746000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Changes In Cash: -360000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Common Stock: 32514000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -4196000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 3661000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Common Stock Payments: -6360000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Construction In Progress: 1213000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 6406000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 9093000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Current Assets: 22186000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Current Debt: 1591000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 1591000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 15687000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Current Provisions: 548000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Deferred Income Tax: -1198000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Deferred Tax: -1198000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Depreciation: 3417000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 3417000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 3417000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 9829124040.00
AMGN.TO income_statement (annual, 2022-12-31) — Diluted EPS: 0.67
AMGN.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 6552000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Dividends Payable: 1137000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 700000000.00
AMGN.TO income_statement (annual, 2022-12-31) — EBIT: 8752000000.00
AMGN.TO income_statement (annual, 2022-12-31) — EBITDA: 12169000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 891000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — End Cash Position: 7629000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: -4037000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Finished Goods: 1004000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Foreign Currency Translation Adjustments: -348000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: 8785000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 127000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: 567000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -231000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Goodwill: 15529000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 31609000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 14710000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Gross Profit: 19917000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Income Tax Payable: 1195000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Interest Expense: 1406000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 1406000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Interest Payable: 470000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Inventory: 4930000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 42606000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -6044000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 6919000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Land And Improvements: 292000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Long Term Debt: 37354000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 37354000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 6919000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 4320000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -3839000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -6360000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Net Debt: 31316000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Net Income: 6552000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 6552000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 6552000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 6552000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 6552000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 6552000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 6552000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Net Interest Income: -1406000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -1369000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 6919000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 6919000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -1406000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -400000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 100000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Net PPE: 5427000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -936000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -27948000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 11000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 11000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: 12169000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Normalized Income: 6552000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 9721000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: 1585000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Operating Income: 9566000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Operating Revenue: 24801000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 534000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Other Current Assets: 355000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 117000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Other Income Expense: -814000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 16080000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: -303000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 5899000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 2651000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -814000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Other Operating Expenses: 503000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Other Properties: 4684000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 1676000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Payables: 3904000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 12997000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1099000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1204000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Pretax Income: 7346000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Properties: 0.00
AMGN.TO cash_flow (annual, 2022-12-31) — Purchase Of Business: -3839000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -2587000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -936000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Raw Materials: 828000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Receivables: 6392000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 6406000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 3417000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
AMGN.TO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -6360000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Research And Development: 4434000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: -28622000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Sale Of Business: 130000000.00
AMGN.TO cash_flow (annual, 2022-12-31) — Sale Of Investment: 1218000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 5414000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Share Issued: 534000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
AMGN.TO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 401000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 3661000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: -27948000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
AMGN.TO income_statement (annual, 2022-12-31) — Tax Provision: 794000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.11
AMGN.TO balance_sheet (annual, 2022-12-31) — Taxes Receivable: 129000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Total Assets: 65121000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 41015000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Total Debt: 38945000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 3661000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Total Expenses: 16757000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 61460000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 42935000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 45773000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 9566000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 1195000000.00
AMGN.TO income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
AMGN.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 5757000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Unrealized Gain Loss: 0.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Work In Process: 3098000000.00
AMGN.TO balance_sheet (annual, 2022-12-31) — Working Capital: 6499000000.00
AMGN.TO income_statement (annual, 2023-12-31) — +Operating Expense: 11842000000.00
AMGN.TO income_statement (annual, 2023-12-31) — +Total Revenue: 28190000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 1590000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 7268000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -9808000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 851000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 9720113422.00
AMGN.TO income_statement (annual, 2023-12-31) — Basic EPS: 0.69
AMGN.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 7629000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 4507000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -1112000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 33070000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 10944000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 10944000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -4556000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 21048000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -26204000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 8471000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Change In Account Payable: -402000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 935000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: -660000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Change In Inventory: 491000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -564000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -222000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 953000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Change In Payable: -1062000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -127000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Change In Receivables: -1015000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Change In Tax Payable: -660000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: -484000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -1015000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Changes In Cash: 3315000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Common Stock: 33070000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -4556000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 6232000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Construction In Progress: 1550000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 8451000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 11109000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Current Assets: 30332000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Current Debt: 1443000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 1443000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 18392000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Deferred Income Tax: -1273000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Deferred Tax: -1273000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Depreciation: 4071000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 4071000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 4071000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 9774618731.00
AMGN.TO income_statement (annual, 2023-12-31) — Diluted EPS: 0.69
AMGN.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 6717000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Dividends Payable: 1205000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Duefrom Related Parties Current: 502000000.00
AMGN.TO income_statement (annual, 2023-12-31) — EBIT: 10730000000.00
AMGN.TO income_statement (annual, 2023-12-31) — EBITDA: 14801000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 11000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — End Cash Position: 10944000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 21048000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Finished Goods: 2778000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Foreign Currency Translation Adjustments: -298000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: 7359000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -1565000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -289000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Goodwill: 18629000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 51270000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 15749000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Gross Profit: 19739000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Income Tax Payable: 1664000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Interest Expense: 2875000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 2875000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Interest Payable: 936000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Inventory: 9518000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 70845000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -26204000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 27777000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Land And Improvements: 339000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Long Term Debt: 63170000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 63170000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 27777000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -1454000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 4540000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -26989000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Net Debt: 53669000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Net Income: 6717000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 6717000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 6717000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 6717000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 6717000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 6717000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 6717000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Net Interest Income: -2875000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 1673000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 26323000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 26323000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -2875000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -719000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 224000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Net PPE: 5941000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -1112000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -45038000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 2354000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 2354000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Normalized EBITDA: 14801000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Normalized Income: 6717000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: 8471000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Operating Gains Losses: -1565000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Operating Income: 7897000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Operating Revenue: 26910000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 535400000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Other Current Assets: 281000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 9000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Other Income Expense: 2833000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 32641000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: -277000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 9611000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 2326000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 2833000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Other Operating Expenses: 879000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Other Properties: 4813000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 0.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Payables: 4459000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 15568000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1381000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Prepaid Assets: 1647000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Pretax Income: 7855000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Properties: 0.00
AMGN.TO cash_flow (annual, 2023-12-31) — Purchase Of Business: -26989000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Purchase Of Investment: -1000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -1112000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Raw Materials: 993000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Receivables: 7942000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 8451000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 4071000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -1454000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
AMGN.TO income_statement (annual, 2023-12-31) — Research And Development: 4784000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: -26549000000.00
AMGN.TO cash_flow (annual, 2023-12-31) — Sale Of Investment: 1673000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 6179000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Share Issued: 535400000.00
AMGN.TO income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
AMGN.TO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 431000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 6232000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: -45038000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
AMGN.TO income_statement (annual, 2023-12-31) — Tax Provision: 1138000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.15
AMGN.TO balance_sheet (annual, 2023-12-31) — Taxes Receivable: 172000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Total Assets: 97154000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 69402000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Total Debt: 64613000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 6232000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Total Expenses: 20293000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 90922000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 66822000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 72530000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 7897000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 1664000000.00
AMGN.TO income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
AMGN.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 4680000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Unrealized Gain Loss: 0.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Work In Process: 5747000000.00
AMGN.TO balance_sheet (annual, 2023-12-31) — Working Capital: 11940000000.00
AMGN.TO cash_flow (quarterly, 2024-09-30) — Earnings Losses From Equity Investments: 28000000.00
AMGN.TO cash_flow (quarterly, 2024-09-30) — Gain Loss On Investment Securities: -1633000000.00
AMGN.TO cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
AMGN.TO cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
AMGN.TO cash_flow (quarterly, 2024-09-30) — Net Investment Purchase And Sale: 0.00
AMGN.TO cash_flow (quarterly, 2024-09-30) — Sale Of Investment: 0.00
AMGN.TO income_statement (annual, 2024-12-31) — +Operating Expense: 13308000000.00
AMGN.TO income_statement (annual, 2024-12-31) — +Total Revenue: 33424000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 1908000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 6782000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -10388000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 159000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 9756450295.00
AMGN.TO income_statement (quarterly, 2024-12-31) — Basic Average Shares: 9756450295.00
AMGN.TO income_statement (annual, 2024-12-31) — Basic EPS: 0.42
AMGN.TO income_statement (quarterly, 2024-12-31) — Basic EPS: 0.06
AMGN.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 10944000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 4803000000.00
AMGN.TO balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 4803000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -1096000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 33533000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 11973000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 11973000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -4832000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -9415000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -1046000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 11490000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Change In Account Payable: 312000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 1194000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Change In Income Tax Payable: -1503000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Change In Inventory: 2532000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -652000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -51000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 92000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Change In Payable: -1191000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 3000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Change In Receivables: 441000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Change In Tax Payable: -1503000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: 2365000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 441000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Changes In Cash: 1029000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Common Stock: 33533000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -4832000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 5877000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Common Stock Payments: -200000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Construction In Progress: 2053000000.00
AMGN.TO balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 2053000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 12858000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 12451000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Current Assets: 29030000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Current Debt: 3550000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 3550000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 23099000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Deferred Income Tax: -1228000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Deferred Tax: -1228000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Depreciation: 5592000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 5592000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 5592000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 9829124040.00
AMGN.TO income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 9847292476.00
AMGN.TO income_statement (annual, 2024-12-31) — Diluted EPS: 0.42
AMGN.TO income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.06
AMGN.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 4090000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Dividends Payable: 1278000000.00
AMGN.TO balance_sheet (quarterly, 2024-12-31) — Dividends Payable: 1278000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 521000000.00
AMGN.TO balance_sheet (quarterly, 2024-12-31) — Duefrom Related Parties Current: 521000000.00
AMGN.TO income_statement (annual, 2024-12-31) — EBIT: 7764000000.00
AMGN.TO income_statement (annual, 2024-12-31) — EBITDA: 13356000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: -10000000.00
AMGN.TO cash_flow (quarterly, 2024-12-31) — Earnings Losses From Equity Investments: 1000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — End Cash Position: 11973000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: -9415000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Finished Goods: 2060000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Foreign Currency Translation Adjustments: -374000000.00
AMGN.TO balance_sheet (quarterly, 2024-12-31) — Foreign Currency Translation Adjustments: -374000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: 10394000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 159000000.00
AMGN.TO cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: 876000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -66000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Goodwill: 18637000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 46336000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 16931000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Gross Profit: 20566000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Income Tax Payable: 2583000000.00
AMGN.TO balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 2583000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Interest Expense: 3155000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 3155000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Interest Payable: 867000000.00
AMGN.TO balance_sheet (quarterly, 2024-12-31) — Interest Payable: 867000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Inventory: 6998000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 65976000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -1046000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
AMGN.TO cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Land And Improvements: 346000000.00
AMGN.TO balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 346000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Long Term Debt: 56549000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 56549000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
AMGN.TO cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
AMGN.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -3600000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 4733000000.00
AMGN.TO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 4733000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
AMGN.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -200000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Net Debt: 48126000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Net Income: 4090000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 4090000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 4090000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 4090000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 4090000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 4090000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 4090000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Net Interest Income: -3155000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
AMGN.TO cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
AMGN.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -3600000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -3600000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -3155000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -783000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 50000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Net PPE: 6543000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1096000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: -40459000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 1616000000.00
AMGN.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 1616000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: 13356000000.00
AMGN.TO income_statement (annual, 2024-12-31) — Normalized Income: 4090000000.00
AMGN.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 11490000000.00